At A Glance
- FOXO4-DRI is an experimental peptide studied in senescent cells—cells that have stopped dividing but remain biologically active. It appears in longevity conversations because researchers are interested in how these cells influence aging tissues.
- The 2017 study reported senescent-cell apoptosis and improvements in selected measures in aged or chemotherapy-exposed mice.
- The peptide’s structure is central to its research identity.
What Is FOXO4?
FOXO4-DRI is an experimental peptide studied in senescent cells—cells that have stopped dividing but remain biologically active. It appears in longevity conversations because researchers are interested in how these cells influence aging tissues.
The design aims to disturb an interaction between FOXO4 and p53 that can help senescent cells survive. In selected models, disrupting that interaction encourages those cells to undergo programmed cell death.
Why Is Senescence An Interesting Target?
Aging research looks at both how cells change and how those changed cells affect their surroundings. FOXO4-DRI explores the possibility of selectively removing some senescent cells. A 2017 mouse study helped bring attention to that approach.
Why Keep “DRI” In The Name?
FOXO4 is also the name of a protein. FOXO4-DRI is a particular peptide design with reversed sequence orientation and D-amino-acid chemistry. Those details help define the material used in the study, so the shorter label alone is not enough to identify it.
A Closer Look At FOXO4
Here are the key observations and the context that helps explain them. The original sources are linked below if you would like to explore further.
| Study or context | What was explored | What it tells us | Useful context |
|---|---|---|---|
| Cell and mouse research | Senescent-cell targeting | The 2017 study reported senescent-cell apoptosis and improvements in selected measures in aged or chemotherapy-exposed mice. | This was not a human longevity trial. |
| Molecular identity | The D-retro-inverso design | The peptide’s structure is central to its research identity. | A FOXO4-labelled material needs that exact design confirmed before connecting it to the paper. |
Common Questions About FOXO4
What is FOXO4?+
FOXO4-DRI is an experimental peptide studied in senescent cells—cells that have stopped dividing but remain biologically active. It appears in longevity conversations because researchers are interested in how these cells influence aging tissues.
Why is senescence an interesting target?+
Aging research looks at both how cells change and how those changed cells affect their surroundings. FOXO4-DRI explores the possibility of selectively removing some senescent cells. A 2017 mouse study helped bring attention to that approach.
Why keep “DRI” in the name?+
FOXO4 is also the name of a protein. FOXO4-DRI is a particular peptide design with reversed sequence orientation and D-amino-acid chemistry. Those details help define the material used in the study, so the shorter label alone is not enough to identify it.
Sources
Want to go a little deeper? These links take you to the studies and official records behind the guide. Study registries describe the plan; published papers report the findings.
- the primary Cell paperPeer-reviewed publication · Linked record
A 2017 study reported that FOXO4-DRI promoted apoptosis in senescent cells and improved several measures in aged and chemotherapy-exposed mice. It was not a human longevity trial.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
For FOXO4 context, this official Canadian advisory explains why a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Vote For FOXO4
This compound is not currently stocked. Add it to your five-choice catalogue ballot.